why is compound tirzepatide banned Compounded Tirzepatide: Legal & Safe 2026 FDA Proposes Ban on Bulk

community and clinical sources describe dermatological monitoring for these changes, especially with long-term use Injection site darkening localized hyperpigmentation Mood changes irritability reported by some during loading Managing nausea: community sources commonly describe beginning at 100-250 mcg, injecting before bed on an empty stomach, using anti-nausea medication (ondansetron) when needed, and escalating the dose gradually

Xu M, Sakamoto S, Matsushima J, Kimura T, Ueda T, Mizokami A, et al

They require dose escalation over weeks to months, and full therapeutic effects may not appear until you reach the maintenance dose

By drug class, the long-acting GLP-1 agonists segment held a dominant position in the market with a 63% share in 2025